<?xml version="1.0" encoding="UTF-8"?>
<p id="Par11">The primary objective is to demonstrate that the omission of prophylactic platelet transfusion in severely thrombocytopenic patients does not increase the amount of bleeding complications related to CVC placement.</p>
